Bilal Chughtai, MD, an associate professor of Urology at Weill Cornell Medical College, explains why he believes it is an “exciting time” for extracts, such as saw palmetto, for the treatment of patients with benign prostatic hyperplasia and lower urinary tract symptoms. Chughtai was part of an international panel of leading urologists from North America and Europe who published the consensus paper, “Rethinking the Role of Saw Palmetto Extract for Men with Lower Urinary Tract Symptoms in North America.” In the conclusion of the paper, Chughtai and colleagues wrote that after reviewing the evidence they recommend that saw palmetto extract “be considered as a treatment option for men with mild-to-moderate BPH/LUTS as an alternative to watchful waiting.”
Academic, private practice urologists collaborate to change BPH reimbursement
April 1st 2024"We really aimed to affect 3 different contraindications and instead achieved retirement of the entire policy, which, we think, really opens up this wonderful technology to literally hundreds of thousands more patients across the country," says Arpeet Shah, MD.